Durand T - Search Results

1

Understanding FAHFAs: From structure to metabolic regulation.

Brejchova K, Balas L, Paluchova V, Brezinova M, Durand T, Kuda O. Brejchova K, et al. Among authors: durand t. Prog Lipid Res. 2020 Jul;79:101053. doi: 10.1016/j.plipres.2020.101053. Epub 2020 Jul 29. Prog Lipid Res. 2020. PMID: 32735891 Review.

2

Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues.

El Fangour S, Balas L, Rossi JC, Fedenyuk A, Gretskaya N, Bobrov M, Bezuglov V, Hillard CJ, Durand T. El Fangour S, et al. Among authors: durand t. Bioorg Med Chem Lett. 2003 Jun 16;13(12):1977-80. doi: 10.1016/s0960-894x(03)00348-2. Bioorg Med Chem Lett. 2003. PMID: 12781177

3

Synthesis of a photoactivatable probe of the anandamide re-uptake.

Balas L, Hellal M, Rossi JC, Durand T. Balas L, et al. Among authors: durand t. Nat Prod Res. 2005 Jun;19(4):419-23. doi: 10.1080/14786410500057015. Nat Prod Res. 2005. PMID: 15938150

4

Synthesis of a potential photoactivatable anandamide analog.

Balas L, Cascio MG, Di Marzo V, Durand T. Balas L, et al. Among authors: durand t. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3765-8. doi: 10.1016/j.bmcl.2006.04.059. Epub 2006 May 6. Bioorg Med Chem Lett. 2006. PMID: 16682198

5

Total Synthesis of the Four Enantiomerically Pure Diasteroisomers of the Phytoprostanes E1Type II and of the 15-E2t-Isoprostanes.

Pinot E, Guy A, Fournial A, Balas L, Rossi JC, Durand T. Pinot E, et al. Among authors: durand t. J Org Chem. 2008 Apr 18;73(8):3063-9. doi: 10.1021/jo702455g. Epub 2008 Mar 20. J Org Chem. 2008. PMID: 18351775

6

Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity.

Balas L, Durand T, Saha S, Johnson I, Mukhopadhyay S. Balas L, et al. Among authors: durand t. J Med Chem. 2009 Feb 26;52(4):1005-17. doi: 10.1021/jm8011382. J Med Chem. 2009. PMID: 19161308

7

The handy use of Brown's P2-Ni catalyst for a skipped diyne deuteration: application to the synthesis of a [D4]-labeled F4t-neuroprostane.

Oger C, Bultel-Poncé V, Guy A, Balas L, Rossi JC, Durand T, Galano JM. Oger C, et al. Among authors: durand t. Chemistry. 2010 Dec 17;16(47):13976-80. doi: 10.1002/chem.201002304. Chemistry. 2010. PMID: 21077063 No abstract available.

8

F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome.

De Felice C, Signorini C, Durand T, Oger C, Guy A, Bultel-Poncé V, Galano JM, Ciccoli L, Leoncini S, D'Esposito M, Filosa S, Pecorelli A, Valacchi G, Hayek J. De Felice C, et al. Among authors: durand t. J Lipid Res. 2011 Dec;52(12):2287-2297. doi: 10.1194/jlr.P017798. Epub 2011 Sep 13. J Lipid Res. 2011. PMID: 21917727 Free PMC article.

9

Are alkyne reductions chemo-, regio-, and stereoselective enough to provide pure (Z)-olefins in polyfunctionalized bioactive molecules?

Oger C, Balas L, Durand T, Galano JM. Oger C, et al. Among authors: durand t. Chem Rev. 2013 Mar 13;113(3):1313-50. doi: 10.1021/cr3001753. Epub 2012 Nov 29. Chem Rev. 2013. PMID: 23194255 Review. No abstract available.

10

Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date.

Balas L, Guichardant M, Durand T, Lagarde M. Balas L, et al. Among authors: durand t. Biochimie. 2014 Apr;99:1-7. doi: 10.1016/j.biochi.2013.11.006. Epub 2013 Nov 18. Biochimie. 2014. PMID: 24262603 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters